Author: Neel Achary

India Accelerates Clean Energy Push with Bids Invited for 10 GWh Advanced Battery Manufacturing Capacity

July 15: The government has invited bids for establishing giga-scale Advanced Chemistry Cell (ACC) battery manufacturing facilities with a combined capacity of 10 GWh, marking a significant move to strengthen India’s clean energy and advanced manufacturing capabilities.

The initiative is aimed at creating a strong domestic ecosystem for next-generation battery technologies, reducing reliance on imports, and supporting the rapidly growing demand for energy storage solutions in sectors such as electric mobility, renewable energy, and industrial applications.

Through the bidding process, the government seeks to encourage investment in large-scale battery manufacturing and promote innovation across the energy storage value chain. The proposed facilities are expected to boost production capacity, generate employment opportunities, and support the development of related industries.

ACC batteries are a key component in the transition towards cleaner transportation and sustainable energy systems. Building domestic manufacturing capabilities in this sector will help India strengthen its position in the global clean technology landscape.

The initiative is part of the government’s broader efforts to promote self-reliance in strategic technologies, accelerate the adoption of electric vehicles, and create a future-ready energy ecosystem.

The development of giga-scale battery manufacturing facilities is expected to provide fresh momentum to India’s green growth ambitions while opening new opportunities for industry and innovation.

Regency Fincorp Board Approves Issuance of INR 40 Crore Secured NCDs to Strengthen Capital Base

Zirakpur, 15th July: Regency Fincorp Limited, a leading NBFC focused on providing accessible and customer-centric financial solutions, today announced that its Board of Directors, at a meeting held on July 14, 2026, approved the issuance of Secured, Rated, Listed, Non-Convertible Debentures (NCDs) aggregating up to ₹40 crore on a private placement basis. The proposed issuance will further strengthen the Company’s capital base and support its ongoing focus on secured lending and portfolio growth.

Commenting on the board’s approval, Mr. Gaurav Kumar, Managing Director, Regency Fincorp Limited, said: “This approval marks another step in strengthening our capital base as we continue to scale our secured lending franchise. Raising funds through a rated, secured NCD structure reflects the confidence our lenders place in Regency Fincorp’s governance and credit discipline. As India’s NBFC sector continues to evolve, we remain focused on building a diversified funding profile that supports sustainable, long-term growth while staying true to our core mission of expanding access to credit for MSMEs and underserved borrowers.”

Key Appointments for the Issuance

To facilitate the NCD issuance, the Board approved the appointment of Catalyst Trusteeship Limited as Debenture Trustee, Credora Partners Private Limited as Merchant Banker, and Infomerics Valuation and Rating Limited as Credit Rating Agency.

The White One Production Enters the Entertainment Industry with a Focus on Artist Management and Creative Productions

The launch soirée in Gurugram brought together artists, industry leaders, creators and entertainment professionals to celebrate the company’s vision for the future of India’s creative ecosystem

(L-R) Shekhar Sharma (Co-Founder, The White One Production) with Saurabh Singh Parihar (Founder, The White One Production)

Gurugram, July 15: The White One Production successfully celebrated its official launch with an exclusive evening of music, networking and entertainment at Club Diego, Gurugram. The event marked the beginning of the company’s journey as an integrated platform for artist management, music production, video production, branded content and live entertainment. The launch brought together a vibrant mix of artists, creators, entertainment professionals, brand partners, influencers and industry stakeholders, who gathered to celebrate the company’s vision of creating meaningful opportunities for emerging talent while delivering world-class creative and entertainment experiences. The evening featured immersive performances, curated entertainment, premium hospitality and engaging conversations that reflected The White One Production’s commitment to building a collaborative ecosystem where artists, brands and audiences come together through creativity and innovation.

Designed as more than just a launch celebration, the event showcased the company’s integrated approach to entertainment—combining artist development, music and video production, live experiences and strategic collaborations under one unified platform. The White One Production represents an exciting roster of Indian and international electronic music artists, including internationally acclaimed names such as Ege Sağlam and Lila Kova, alongside Indian talents Freqisht, Voystra, SubKNTKT, MASKERA and ENJEY. The company aims to nurture artists by providing strategic management, bookings, brand collaborations and creative production that enables sustainable career growth. Further strengthening its offering, The White One Production has partnered with BestEve to establish The White One × BestEve Events, delivering premium concerts, club shows, festivals, corporate events, luxury weddings and brand activations through world-class production and seamless event execution.

Reflecting on the successful launch, Saurabh Singh Parihar, Founder, The White One Production, said: “The launch evening was a reflection of everything The White One Production stands for—bringing together artists, creators and industry partners under one roof to celebrate collaboration and creativity. We are grateful for the overwhelming support and excited to begin this journey of creating meaningful opportunities for talent while producing experiences that leave a lasting impact.”

Shekhar Sharma, Co-Founder, The White One Production, added: “The response to our launch has been incredibly encouraging. It reinforces our belief that the industry is ready for an integrated platform that combines artist management, music and video production, creative storytelling and premium live entertainment. This is only the first step, and we look forward to building a strong community around music, culture and innovation.”

With its official launch now complete, The White One Production is set to expand its portfolio across artist management, original music and video production, branded content, live entertainment and experiential events, while building long-term collaborations with artists, brands and creative partners across India and internationally. 

Bharat Tex 2026: India’s Textile Sector Charts a New Path Towards Global Leadership

July 15: Bharat Tex 2026 has emerged as a reflection of India’s ambitious vision to transform the textile sector into a globally competitive and future-ready industry, Prime Minister Narendra Modi said while highlighting the sector’s crucial role in the country’s economic growth.

The Prime Minister said the event represents India’s Vision 2030 roadmap for textiles, focusing on innovation, advanced manufacturing, sustainable practices, and expanding the global footprint of Indian textile products.

Emphasising the importance of the sector, PM Modi noted that textiles are not only linked to India’s rich heritage of craftsmanship but also represent a major opportunity for economic development, entrepreneurship, and job creation.

Bharat Tex 2026 brings together stakeholders from across the textile value chain, including manufacturers, designers, exporters, innovators, and industry leaders, providing a platform for collaboration, investment, and global partnerships.

The Prime Minister highlighted the need to strengthen technology adoption, improve product quality, promote sustainable manufacturing, and empower artisans and businesses to compete effectively in international markets.

With India’s traditional strengths combined with modern innovation, the textile sector is expected to play a key role in achieving the vision of a developed India by creating new opportunities for growth and employment.

Bharat Tex 2026 marks an important milestone in India’s journey to position itself as a leading global textile hub, blending heritage with technology and sustainability for the future.

ten23 health expands excipient options for biologic drug development with an external collaboration

Basel, Switzerland. July 15 — ten23 health® today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products. By combining complementary expertise, the collaboration aims to address one of the longstanding challenges in biologic formulation development: the limited availability of excipients suitable for injectable medicines. 

As biologic therapies become increasingly complex, formulation scientists face growing challenges in achieving product stability, manufacturability, and long-term performance. While excipients play a critical role in addressing these challenges, relatively few are available for parenteral biologic applications, limiting formulation flexibility. 

Through this collaboration, ten23 health contributes its expertise in formulation development for sterile products, analytical characterization and pharmaceutical manufacturing, while dsm-firmenich brings extensive capabilities in pharmaceutical ingredient science, quality systems and regulatory support. Together, the teams are evaluating pharmaceutical-grade ingredients with established safety profiles as potential excipient candidates for biologic formulations.

The research follows a structured scientific approach, including proof-of-concept studies, benchmarking against established excipients and evaluation in representative protein formulations using advanced analytical methods. Initial findings have identified promising candidates, which are currently undergoing further verification and characterization. 

“Our approach has been to identify promising ingredients based on their safety profiles, regulatory acceptance, and suitability for biologic formulations,” said Prof. Dr. Andrea Allmendinger, Chief Scientific Officer at ten23 health. “Following proof-of-concept studies and advanced analytical evaluation in representative protein formulations, we have generated promising initial data, which is now being further verified.” 

When successful, the collaboration could help pharmaceutical developers improve formulation stability, enhance manufacturability and increase flexibility during product development. Expanding excipient options may also contribute to more efficient development processes and support the design of drug products better suited to patient needs, including self-administration and improved usability. 

The collaboration reflects a shared commitment by both organizations to advancing biologic drug development through scientific excellence, responsible innovation and cross-disciplinary collaboration.

Gujarat’s Shipbuilding Sector Gets Fresh Push with Centre’s Project Approval

July 15: The Centre has approved two major shipbuilding projects in Gujarat under a development scheme aimed at strengthening India’s maritime manufacturing capabilities and promoting growth in the shipbuilding sector.

The projects are expected to enhance domestic shipbuilding infrastructure, encourage investment, and support the expansion of India’s maritime ecosystem. The initiative is part of the government’s broader efforts to improve self-reliance in strategic sectors and position India as a competitive player in global shipbuilding.

Officials said the projects will help develop advanced shipbuilding facilities while creating new opportunities for industries, skilled workers, and allied sectors connected to maritime activities.

The initiative is also expected to contribute to employment generation, technology development, and improved capabilities in ship construction and related services.

With Gujarat’s strong coastal advantage and growing industrial base, the approved projects are likely to play an important role in strengthening the state’s position as a key maritime hub.

The move reflects the government’s continued focus on expanding India’s blue economy, enhancing manufacturing capacity, and building a stronger presence in the global maritime industry.

Zeelab Pharmacy Crosses 300 Company-Owned Stores, Strengthens Omni-channel Growth with 5,000 Daily Online Orders

New Delhi, 15th July: Zeelab Pharmacy, one of India’s fastest-growing pharmacy retail brands, has crossed 300 company–owned company-operated (COCO) stores and 5,000 daily orders through its e-commerce platform, marking a major milestone in its omni–channel growth journey. The achievement reinforces Zeelab’s position as one of India’s fastest-scaling pharmacy networks, driven by a technology-enabled omni–channel model focused on making quality healthcare more accessible and affordable.

The company achieved the 300-store milestone while its digital platform surpassed 5,000 daily orders within just four years of launch, reflecting strong customer adoption across metropolitan cities as well as Tier II and Tier III markets. Together, these milestones highlight the growing acceptance of Zeelab’s integrated “phygital” healthcare model, which combines a company–owned retail network with digital convenience to deliver affordable medicines at scale.

Over the last six months, Zeelab has expanded its footprint by adding nearly 15 company–owned stores every month, with its strongest presence across Delhi-NCR, Uttar Pradesh, Maharashtra and West Bengal. By March 2027, it aims to achieve 15,000 daily online orders, 35,000 daily offline orders and a significantly larger retail footprint.

Commenting on the milestone, Rohit Mukul, Founder and Chief Executive Officer, Zeelab Pharmacy, said, “Crossing 300 company–owned stores is more than a growth milestone, it reflects our conviction that quality healthcare can be made affordable at scale. India remains one of the world’s largest pharmaceutical markets, yet out-of-pocket healthcare expenditure continues to place a significant burden on millions of families. At Zeelab, we are addressing this gap by combining an integrated retail network, technology-led operations and a robust supply chain to make trusted, high-quality medicines accessible to more people. As we continue to expand, our ambition is clear, to build India’s most trusted affordable healthcare platform by setting new benchmarks in accessibility, affordability and customer experience.”

Zeelab’s integrated omni–channel model has become a key growth driver, enabling customers to access medicines seamlessly through both physical stores and digital channels. Pharmaceutical products account for approximately 60% of the company’s business, while wellness, personal care and over-the-counter healthcare products contribute the remaining 40%. Online demand continues to be led by chronic therapies, including diabetes and cardiac medicines, alongside rapidly growing skincare and haircare categories. The platform currently offers more than 1,200 products, serving customers across urban and emerging markets.

The company’s affordability-led model is also improving healthcare outcomes by enabling more consumers to purchase complete prescribed treatment regimens, supporting better treatment adherence. To guide future expansion, Zeelab leverages AI-enabled location intelligence, e-commerce demand heat maps and retail performance analytics to identify underserved, high-potential markets and optimise network expansion.

Looking ahead, Zeelab plans to accelerate its expansion across high-growth markets, including Uttar Pradesh, Bihar, Delhi-NCR, Telangana and West Bengal, while strengthening its presence in existing geographies. The company will continue to build its integrated healthcare ecosystem and advance its mission of making quality healthcare affordable and accessible to millions of Indians.